Swallowing abnormalities and their response to treatment in Parkinson's disease
- 1 October 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (10) , 1309
- https://doi.org/10.1212/wnl.39.10.1309
Abstract
We investigated swallowing abnormalities in patients with Parkinson9s disease, the relationship between these abnormalities and general parkinsonian signs, as well as the response to therapy. Twenty patients and 13 controls were evaluated with clinical rating scales and modified barium swallows before and after oral levodopa (in combination with carbidopa). Fifteen patients, but only 1 control, had abnormal swallows (χ2 = 11.722, df = l, p < 0.001). Abnormalities included disturbances of oral and pharyngeal phases of swallowing. Patients without dysphagia frequently had abnormal swallows, including silent aspiration. Seven patients had improved swallowing after levodopa, whereas 1 worsened. Improvement in general parkinsonian signs was not a reliable indicator of improved swallowing.This publication has 5 references indexed in Scilit:
- Swallowing and speech production in Parkinson's diseaseAnnals of Neurology, 1986
- Regional blood flow in herniparkinsonismNeurology, 1985
- Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1978
- The Measurement of Observer Agreement for Categorical DataPublished by JSTOR ,1977
- ParkinsonismNeurology, 1967